Document:

exv10w1

 

Exhibit 10.1

AMENDED and RESTATED

EMPLOYMENT AGREEMENT

     THIS AMENDED and RESTATED EMPLOYMENT AGREEMENT, dated February 11, 2005, supersedes and
replaces in its entirety the Employment Agreement entered by and among CHRONIMED INC., a Minnesota
corporation (the “Company”), and Anthony J. Zappa (the “Employee”), dated March 1, 2003.

     1. Engagement. The Company agrees to employ the Employee and the Employee accepts such
employment on the terms and conditions set forth in this Agreement and, except to the extent
superceded by this Agreement, subject to those policies and procedures applying to the employees of
the Company, as may be amended from time to time. The Employee shall apply his best efforts and
devote substantially all of his time and attention to the Company’s affairs. Employee’s title
within the Company shall be Executive Vice President, Operations. Employee shall perform those
duties as may from time to time be assigned to him consistent with the offices held by Employee.

     2. Compensation. As consideration for the covenants and agreements herein and Employee’s
services rendered, the Company shall provide Employee the following compensation:

     A. Base Salary. The Employee shall be paid an annual base salary of
$230,000.00 during the term of this Agreement, with increases if any as determined
by the Company’s Board of Directors, payable on the 15th and last day of
each month by direct deposit to a bank account designated by Employee.

     B. Bonus. The Employee shall participate in a Company management incentive
compensation plan, commencing with a plan applicable to the Company’s fiscal year
beginning July 1, 2002, which is designed to offer employee the potential for an
annual bonus targeted at 40% of base salary and up to 60% of base salary. Employee
shall meet with the Company’s Chief Executive Officer to establish qualitative and
quantitative initiatives and objectives for the purpose of assessing the amount of
bonus to be paid Employee at the end of the bonus period.

     C. Stock Options and Incentives. Employee shall be eligible to participate in
annual stock options and incentives consistent with option and incentive plans made
available to the management of the Company and pursuant to the Company’s Board of
Director’s discretion. The terms of future stock options or incentives, including
the number of shares available, exercise price, and vesting provisions shall be
determined pursuant to each option or incentive agreement.

     D. Employee Benefit Plans, Insurance, and Time-Off. During the term of his
employment, Employee shall be entitled to participate in any employee benefit plan
or plans established and maintained by the Company for comparable

1

 

employees, in accordance with the eligibility requirements and other terms and
provisions of such plan or plans. Employee acknowledges and agrees that the Company
is under no obligation to Employee to establish or maintain any employee benefit
plan in which Employee may participate, and that the terms and provisions of any
employee benefit plan of the Company are matters solely within the exclusive
province of the Board of Directors. Employee shall be entitled to receive health,
life, and disability insurance coverage on terms consistent with the Company’s
insurance offerings to comparable employees. Employee shall receive vacation and
medical time-off pursuant to the Company’s standard employee policies.

     3. Term and Termination. The term of this Agreement shall commence on February 1, 2003, and
shall continue thereafter until terminated according to this Section 3. This Agreement shall
earlier terminate upon the occurrence of any of the following:

     A. Written agreement of the parties to terminate;

     B. Employee’s death or Employee’s eligibility for and receipt of long-term disability benefits
under a Company sponsored plan of disability insurance;

     C. Following 45 days written notice by one party to the other indicating the party’s intention
to terminate without cause; or

     D. Termination by the Company for Cause. Cause shall be defined as (i) Employee’s gross
negligence or willful misconduct in the performance of Employee’s duties; (ii) the commission by
Employee of any criminal act, act of fraud or dishonesty by Employee related to, or in connection
with his employment by the Company, or conviction of a crime for which a sentence of more than 90
days incarceration may be imposed; or (iii) Employee’s persistent failure to meet the reasonable
expectations of or duties consistent with the office held by Employee.

     E. Change of Control, if the Change of Control Date occurs on or before June 14, 2005.

	 	(i)  	Definitions. For purposes of this Agreement, “Change of Control” shall be defined as
follows:
	 
	 	a.  	When, subsequent to the effective date of this Agreement, any “person” as
defined in Section 3(a)(9) of the Securities Exchange Act of 1934, as amended (the
“Securities Exchange Act”), as used in Sections 13(d) and 14(d) thereof, including a
“group” as defined in Section 13(d) of the Securities Exchange Act, but excluding the
Company or any subsidiary or parent or any employee benefit plan sponsored or
maintained by the Company or any subsidiary or parent (including any trustee of such
plan acting as trustee), directly or indirectly, becomes the “beneficial owner” (as
defined in Rule 13d-3 under the Securities Exchange Act, as amended from time to time),
of securities of the Company representing greater

2

 

	 	   	than 50 (fifty) percent of the combined voting power of the Company’s then
outstanding securities; or

	 	b.  	When, subsequent to the effective date of this Agreement, the individuals who,
at the beginning of such period, constitute the Board (“Incumbent Directors”) cease for
any reason other than death to constitute at least a majority
thereof; provided,
however, that a director who was not a director at the beginning of this period
will be deemed to have satisfied the definition of “Incumbent Director” if such
director was elected by, or with the approval of, at least 60% (sixty percent) of the
directors who then qualified as Incumbent Directors; or
	 
	 	c.  	Any sale, lease, exchange or other transfer (in one transaction or a series of
related transactions) of all or substantially all of the assets of the Company or the
approval by the shareholders of the Company of any such transaction, whichever first
occurs, or the adoption of any plan or proposal for the liquidation or dissolution of
the Company.

     For purposes of this Agreement, the “Change of Control Date’ shall mean the first date on
which an event constituting a Change of Control occurs.

     For purposes of this Agreement, the “Surviving Entity” shall mean the Company or its
successor, or the parent of the Company or its successor if the Company or its successor becomes a
subsidiary of another entity as a result of a Change in Control.

     (ii) In the event a Change of Control occurs or is agreed to, the Company or the Surviving
Entity shall either (i) offer to Employee a position with the Company or the Surviving Entity after
the Change of Control, or (ii) advise (“Termination Advice”) the Employee that there will not be a
position for the Employee after the Change of Control and that the Employee will be terminated by a
specified date. Where a position is offered to the Employee, the offer (the “Offer”) shall specify
(a) the entity (the “Employer”) that will employ Employee after the Change of Control, (b) the
title, authority, duties and responsibilities that the Employee will have, (c) the base salary, (d)
the terms of any incentive compensation, bonus and stock option opportunities, (e) employee benefit
plans, programs, and policies then in effect which will apply to Employee and (f) the terms of the
non-competition agreement, which shall terminate one year after the termination of employment with
Company, the Surviving Entity and their affiliates and related entities (the “Company Affiliates”),
and confidentiality agreement to be entered into by the Employee. The Offer or Termination Advice
will be provided to the Employee no later than thirty (30) days after the Change of Control Date,
and may be provided in advance of said Date where feasible.

     Where an Offer is extended, the Employee shall have thirty (30) days to consider and discuss
the Offer. The Employee may accept or decline the Offer in the Employee’s sole discretion. If
Employee declines the Offer, the Employee shall be entitled to receive the Severance Benefits
effective upon the Employee’s termination of employment with Company, the Surviving Entity and the
Company Affiliates (“Employment Termination”). If Employee accepts the Offer, Employee shall be
protected under this Agreement as provided in Section 2 for a period of one year after the Change
of Control.

3

 

     If Employee receives Termination Advice, the Employee shall be entitled to receive the
Severance Benefits effective upon the Employment Termination.

     (iii) One Year Period After Offer. If Employee accepts an Offer, then, during the one year
period commencing on the date the Employee begins performing services in accordance with the Offer,
if (i) Employee terminates his or her employment for Good Reason, or (ii) Company delivers a notice
of termination of this Agreement or fails to assign this Agreement to a successor employer, then
Employee shall be entitled to receive the Severance Benefits.

     “Good Reason” means (for purposes of this Agreement):

	 	a.  	Action by the Employer that results in the material diminution of Employee’s
position, authority, duties or responsibilities as set forth in the Offer absent
Employee’s written consent;
	 
	 	b.  	Employer’s assignment to Employee of duties inconsistent with Employee’s
position as set forth in the Offer absent Employee’s written consent;
	 
	 	c.  	Reduction in Employee’s salary or material reduction in Employee’s bonus, long
term compensation, retirement or welfare benefits as set forth in the Offer absent
Employee’s written consent; or
	 
	 	d.  	Except as set forth in the Offer or agreed to in writing by Employee, Employer
requiring that Employee maintain Employee’s home or principal place of business
outside the Minneapolis/St. Paul metropolitan area.

     4. Severance Benefits. In the event that the Employee is entitled to severance pursuant to
the provisions of Section 3.E, or the Employer terminates this Agreement without Cause under
Section 3.C., then Employee shall receive (in lieu of any severance under any other plan, policy or
other arrangement for the benefit of Employee or for the Employer’s employees generally) the
following payments and benefits (the “Severance Benefits”):

	 	i.  	Employee shall receive regular pay through date of Employment Termination (the
“Termination Date”), including pro-rated bonus (such bonus amount determined as under
Section 4.ii) earned for the partial year, if any;
	 
	 	ii.  	Employee shall receive payments equal to twelve (12) months of Employee’s then
current annualized salary, payable monthly, plus an amount equal to the average of any
bonus or incentive compensation paid or payable to the Employee for the two most recent
fiscal years, payable in equal monthly installments; and
	 
	 	iii.  	All unvested stock options held by the Employee shall immediately vest.

     Other than the Severance Benefits identified above, the Company shall have no obligation past
the Termination Date to provide Employee with severance payments or employee benefits except for
(a) benefits generally payable to terminated employees under 401(k) plans, qualified

4

 

benefits plans, and other employee benefit plans and (b) as may be mandated by state or
federal benefits continuation laws.

     5. Covenant Not to Compete. Employee hereby covenants and agrees that during the term of this
Agreement and until the later of (i) one year following termination of this Agreement or any
renewal thereof, or (ii) Employee’s receipt of the last of any severance payments to Employee under
Section 4, Employee shall not be engaged within the United States, either directly or indirectly,
in any manner or capacity, whether as an advisor, principal, agent, partner, officer, director,
employee, or otherwise, in any business or activity, or own beneficially or of record five per cent
(5%) or more of the outstanding stock of any class of equity securities in any corporation, in
competition with the business then being conducted by the Company, its subsidiaries or affiliates,
which business includes but may not be limited to the distribution of medications for treatment of
chronic illnesses, the management of chronic disease states, and all research, analysis, and data
services related to the foregoing. The foregoing prohibition against competition includes, but is
not limited to, solicitation of any Company customer, patient, or referral source. The
restrictions herein shall not preclude Employee from practicing as a dispensing pharmacist in a
non-management capacity. Further, Employee will not for one year following termination of his
employment directly or indirectly attempt to hire away any then-current employee of the Company,
its subsidiaries or affiliates, or take any action to persuade any such employee to leave
employment with the Company, its subsidiaries or affiliates.

     6. Confidentiality. Employee will in the course of his employment with the Company have
access to confidential or proprietary data or information belonging to the Company, its
subsidiaries or affiliates. Employee will not at any time divulge or communicate to any person
(other than to a person bound by confidentiality obligations to the Company similar to those
contained in this Agreement) or use to the detriment of the Company, its subsidiaries or
affiliates, or for the benefit of any other person Confidential or Proprietary Data or Information.
The provisions of this Section 6 shall survive Employees’ employment hereunder regardless of the
cause of termination of employment or this Agreement and shall remain intact for a period of three
(3) years following termination for any reason. “Confidential or Proprietary Data or Information”
shall mean information Employee learns or develops during the course of employment that derives
economic value by being not generally known or ascertainable by others and includes, without
limitation, financial information, customer lists, supplier lists, trade secrets, secret processes,
computer data and programs, pricing, marketing, and advertising data, strategic or operational
plans, methods of research and testing, management systems and matters related to sales and
marketing techniques. Employee acknowledges and agrees that any Confidential or Proprietary Data
or Information that Employee has already acquired was in fact received in confidence and in
Employee’s fiduciary capacity with respect to the Company.

     All written materials, records and documents made by Employee or coming into Employee’s
possession during the term of employment concerning any product, processes, information or services
used, developed, investigated or considered by the Company, its subsidiaries or affiliates, or
otherwise concerning the business or affairs of the Company, its subsidiaries or affiliates, shall
be the sole property of the Company and upon termination of Employee’s employment for any reason,
or upon request of the Board of Directors during Employee’s employment, Employee shall promptly
deliver the same to the Company. In

5

 

addition, upon termination of Employee’s employment for any reason, or upon request of the Board of
Directors during Employee’s employment, Employee shall deliver to the Company all other property of
the Company in Employee’s possession or under Employee’s control including, but not limited to,
financial statements, marketing and sales data, computer hardware and software, and Company credit
cards.

     7. Other Business Activities. Employee shall not serve as a director, officer, employee,
consultant, independent contractor or agent of another company, whether for-profit, not-for-profit,
charitable organization, foundation or otherwise, during the term of this Agreement without the
express prior consent of the Company’s Board of Directors.

     8. Notices. All notices, requests, demands and other communications provided for by this
Agreement shall be in writing and shall be deemed to have been given when mailed at any general or
branch United States Post Office enclosed in a certified postpaid envelope, return receipt
requested, and addressed to the address of the respective party stated below or to such changed
address as the party may have fixed by notice:

                    If to the Employee:

                    Anthony J. Zappa

                    7110 W. 83rd St.

                    Bloomington, MN 55438

                    If to the Company:

                    Chronimed Inc.

                    10900 Red Circle Drive

                    Minnetonka, MN 55343

                    Attn: Chief Executive Officer

Any notice of change of address shall only be effective, however, when received.

     9. Successors and Assigns. This Agreement shall inure to the benefit of, and be binding upon,
the Company, its successors and assigns, including, without limitation, any corporation which may
acquire all or substantially all of the Company’s assets and business or into which the Company may
be consolidated or merged, and the Employee, his heirs, executors, administrators and legal
representatives. The Employee may not assign his rights or obligations under this Agreement without
the prior consent of the Company. The Company may assign this Agreement to any entity acquiring
substantially all the assets or business of the Company or any subsidiary entity of the Company to
which Employee is assigned, by way of purchase, merger, or otherwise.

     10. Applicable Law. This Agreement shall be governed by the laws of the State of Minnesota.

     11. Other Agreements. This Agreement supersedes all prior understandings and agreements
between the parties. It may not be amended orally, but only by a writing signed by the parties
hereto.

6

 

     12. Non-waiver. No delay or failure by either party in exercising any right under this
Agreement, and no partial or single exercise of that right, shall constitute a waiver of that or
any other right.

     13. Headings. Headings in this Agreement are for convenience only and shall not be used to
interpret or construe its provisions.

     14. Counterparts. This Agreement may be executed in two or more counterparts, each of which
shall be deemed an original but all of which together shall constitute one and the same instrument.

     15. Severability. If any provision of this Agreement is found to be invalid, prohibited, or
unenforceable, such provision shall be deemed modified to the extent necessary to make it valid and
enforceable or, if it cannot be modified, then severed and the remainder of this Agreement shall
remain in full force and effect.

	 	 	 	 	 
	CHRONIMED INC.	 	EMPLOYEE
	 
	 	 	 	 
	By

	 	/S/ Henry F. Blissenbach
	 	/S/ Anthony J. Zappa
	

	 	 
	 	 
	

	 	Chairman and CEO	 	 

7exv10w1

 

EXHIBIT 10.1

The Bank of New York

Corporate Trust and Agency Services

2 North LaSalle Street, Suite 1020

Chicago, IL 60602

Charles Baker

(312) 827-8576

Distribution Date: January 28, 2005

SEQUOIA MORTGAGE FUNDING CORPORATION

Collateralized MBS Funding Bonds, Series 2002-A

Certificate Monthly Distribution Summary

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 
	 	 	 	 	 	 	 	 	 	Beginning Cert	 	 	 	Pass	 	 	 	Interest	 	 	 	Principal	 	 	 	Total	 	 	 	Realized	 	 	 	Ending Cert	 
	 	Class	 	 	CUSIP	 	 	 	Balance	 	 	 	Through	 	 	 	Distribution	 	 	 	Distribution	 	 	 	Distribution	 	 	 	Losses	 	 	 	Balance	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	A-1	 	 	 	81743UAA3	 	 	 	 	9,186,599.81	 	 	 	 	3.020000	%	 	 	 	23,119.61	 	 	 	 	321,183.17	 	 	 	 	344,302.78	 	 	 	 	0.00	 	 	 	 	8,865,416.64	 
	 	A-2	 	 	 	81743UAB1	 	 	 	 	1,259,884.94	 	 	 	 	3.570000	%	 	 	 	3,748.16	 	 	 	 	19,034.93	 	 	 	 	22,783.09	 	 	 	 	0.00	 	 	 	 	1,240,850.01	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	Total	 	 	 	 	 	 	 	 	10,446,484.76	 	 	 	 	 	 	 	 	 	26,867.77	 	 	 	 	340,218.10	 	 	 	 	367,085.87	 	 	 	 	0.00	 	 	 	 	10,106,266.65	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Current Payment Information

Factors per $1.00

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 
	 	 	 	 	 	 	 	 	 	Original Cert	 	 	 	Beginning	 	 	 	Interest	 	 	 	Principal	 	 	 	Ending	 	 	 	Current Pass	 
	 	Class	 	 	CUSIP	 	 	 	Balance	 	 	 	Factor	 	 	 	Factor	 	 	 	Factor	 	 	 	Factor	 	 	 	Through	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	A-1	 	 	 	81743UAA3	 	 	 	 	64,761,000.00	 	 	 	 	141.853890666	 	 	 	 	0.356998958	 	 	 	 	4.959515336	 	 	 	 	136.894375330	 	 	 	 	3.020000	%
	 	A-2	 	 	 	81743UAB1	 	 	 	 	15,861,000.00	 	 	 	 	79.432882063	 	 	 	 	0.236312824	 	 	 	 	1.200109199	 	 	 	 	78.232772864	 	 	 	 	3.570000	%
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	Total	 	 	 	 	 	 	 	 	80,622,000.00	 	 	 	 	129.573624517	 	 	 	 	0.333256025	 	 	 	 	4.219916458	 	 	 	 	125.353708060	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Underlying Certificates Monthly Distribution – Group I

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 
	 	 	 	 	 	 	 	 	 	Original	 	 	 	Beginning	 	 	 	Pass	 	 	 	Interest	 	 	 	Principal	 	 	 	Total	 	 	 	Realized	 	 	 	Interest	 	 	 	Ending	 
	 	Series	 	 	Class	 	 	 	Balance	 	 	 	Balance	 	 	 	Through	 	 	 	Distribution	 	 	 	Distribution	 	 	 	Distribution	 	 	 	Losses	 	 	 	Shortfall	 	 	 	Balance	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	CWMBS 94K
	 	 	 	A1	 	 	 	 	123,119,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	DLJMA 93-Q18
	 	 	 	1A1	 	 	 	 	51,833,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	DLJMA 94-2A
	 	 	 	1A1	 	 	 	 	85,787,000.00	 	 	 	 	275,700.44	 	 	 	 	5.105185	%	 	 	 	1,172.92	 	 	 	 	684.25	 	 	 	 	1,857.17	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	275,016.19	 
	 	ONE 00-2
	 	 	 	2A	 	 	 	 	152,653,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	RYMS3 92-B
	 	 	 	1A2	 	 	 	 	7,712,906.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	SBM7 94-2
	 	 	 	A1	 	 	 	 	49,384,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	SMS 91-K
	 	 	 	A1	 	 	 	 	110,588,063.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	SMS 91-K
	 	 	 	A3	 	 	 	 	1,917,885.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	EAGLE 98-1
	 	 	 	M1	 	 	 	 	46,029,000.00	 	 	 	 	9,165,820.43	 	 	 	 	2.897500	%	 	 	 	25,233.37	 	 	 	 	329,411.51	 	 	 	 	354,644.88	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	8,836,408.93	 
	 	INMC 94-R
	 	 	 	M2	 	 	 	 	4,620,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 94-V
	 	 	 	B1	 	 	 	 	3,618,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 94-X
	 	 	 	B1	 	 	 	 	2,769,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 95-C
	 	 	 	B1	 	 	 	 	12,828,797.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 95-T
	 	 	 	A2	 	 	 	 	65,695,250.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	Total
	 	 	 	 	 	 	 	 	718,554,901.00	 	 	 	 	9,441,520.88	 	 	 	 	 	 	 	 	 	26,406.29	 	 	 	 	330,095.76	 	 	 	 	356,502.05	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	9,111,425.12	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

 

 

Underlying Certificates Monthly Distribution – Group II

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 
	 	 	 	 	 	 	 	 	 	Original	 	 	 	Beginning	 	 	 	Pass	 	 	 	Interest	 	 	 	Principal	 	 	 	Total	 	 	 	Realized	 	 	 	Interest	 	 	 	Ending	 
	 	Series	 	 	Class	 	 	 	Balance	 	 	 	Balance	 	 	 	Through	 	 	 	Distribution	 	 	 	Distribution	 	 	 	Distribution	 	 	 	Losses	 	 	 	Shortfall	 	 	 	Balance	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	GRCAP94-HM4
	 	 	 	A1	 	 	 	 	245,813,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 95-E
	 	 	 	B1	 	 	 	 	4,608,492.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	PMLT 99-A
	 	 	 	M1	 	 	 	 	2,914,000.00	 	 	 	 	1,285,596.88	 	 	 	 	3.400248	%	 	 	 	3,642.79	 	 	 	 	19,423.40	 	 	 	 	23,066.19	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	1,266,173.48	 
	 	RTC 95-2
	 	 	 	A3	 	 	 	 	119,696,000.00	 	 	 	 	0.00	 	 	 	 	0.000000	%	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	Total
	 	 	 	 	 	 	 	 	373,031,492.00	 	 	 	 	1,285,596.88	 	 	 	 	 	 	 	 	 	3,642.79	 	 	 	 	19,423.40	 	 	 	 	23,066.19	 	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	1,266,173.48	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Underlying Pool Delinquent Information by Group

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 
	 	 	 	 	Loans	 	 	 	Delinquent	 	 	 	Delinquent	 	 	 	Delinquent	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	Outstanding	 	 	 	30-59 Days	 	 	 	0-89 Days	 	 	 	90+ Days	 	 	 	Foreclosure	 	 	 	REO	 	 	 	Realized Losses	 
	 	Series	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	Curr. Amount	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	CWMBS 94K
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	DLJMA 93-Q18(1)
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	DLJMA 94-2A(1)
	 	 	 	446,811.97	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	ONE 00-2(2)
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	RYMS3 92-B(2)
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	SBM7 94-2(2)
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	SMS 91-K
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	EAGLE 98-1
	 	 	 	14,962,772.93	 	 	 	 	8	 	 	 	968,201.75	 	 	 	 	2	 	 	 	124,552.46	 	 	 	 	8	 	 	 	1,075,095.09	 	 	 	 	9	 	 	 	868,068.11	 	 	 	 	10	 	 	 	1,059,112.28	 	 	 	 	0.00	 
	 	INMC 94-R
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 94-V
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 94-X
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 95-C
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 95-T(2)
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	Total
	 	 	 	14,962,772.93	 	 	 	 	8	 	 	 	968,201.75	 	 	 	 	2	 	 	 	124,552.46	 	 	 	 	8	 	 	 	1,075,095.09	 	 	 	 	9	 	 	 	868,068.11	 	 	 	 	10	 	 	 	1,059,112.28	 	 	 	 	0.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 
	 	 	 	 	Loans	 	 	 	Delinquent	 	 	 	Delinquent	 	 	 	Delinquent	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	Outstanding	 	 	 	30-59 Days	 	 	 	0-89 Days	 	 	 	90+ Days	 	 	 	Foreclosure	 	 	 	REO	 	 	 	Realized Losses	 
	 	Series	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	No.	 	 	Balance	 	 	 	Curr. Amount	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	GRCAP94-HM4
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	INMC 95-E
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	PMLT 99-A
	 	 	 	19,476,617.82	 	 	 	 	18	 	 	 	1,222,435.81	 	 	 	 	7	 	 	 	306,557.29	 	 	 	 	5	 	 	 	395,653.96	 	 	 	 	11	 	 	 	611,670.44	 	 	 	 	4	 	 	 	207,705.61	 	 	 	 	0.00	 
	 	RTC 95-2(1)
	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0	 	 	 	0.00	 	 	 	 	0.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	Total
	 	 	 	19,476,617.82	 	 	 	 	18	 	 	 	1,222,435.81	 	 	 	 	7	 	 	 	306,557.29	 	 	 	 	5	 	 	 	395,653.96	 	 	 	 	11	 	 	 	611,670.44	 	 	 	 	4	 	 	 	207,705.61	 	 	 	 	0.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	Total All
	 	 	 	34,439,390.75	 	 	 	 	26	 	 	 	2,190,637.56	 	 	 	 	9	 	 	 	431,109.75	 	 	 	 	13	 	 	 	1,470,749.05	 	 	 	 	20	 	 	 	1,479,738.55	 	 	 	 	14	 	 	 	1,266,817.89	 	 	 	 	0.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

	(1)  	Information shown for the Underlying Mortgage Loans for this Pooled Security is based on the
Underlying Mortgage Loan group related to such Pooled Security only.

	 
	(2)  	Information shown for the Underlying Mortgage Loans for this Pooled Security is based on all
the Underlying Mortgage Loan groups in the related series.

 

 

Certificate Account Information

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 
	 	 	 	 	Beginning	 	 	 	Funds	 	 	 	Withdrawals	 	 	 	Management	 	 	 	Available	 	 	 	Funds	 	 	 	Ending	 
	 	Group	 	 	Balance	 	 	 	Deposited	 	 	 	Trustee Fee	 	 	 	Fee	 	 	 	Funds	 	 	 	Distributed	 	 	 	Balance	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	I	 	 	 	0.00	 	 	 	 	356,502.05	 	 	 	 	236.04	 	 	 	 	0.00	 	 	 	356,266.01	 	 	 	344,302.78	 	 	 	 	11,963.23	 
	 	II	 	 	 	0.00	 	 	 	 	  23,066.19	 	 	 	 	  32.14	 	 	 	 	0.00	 	 	 	  23,034.05	 	 	 	  22,783.09	 	 	 	 	     250.96	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	Total	 	 	 	0.00	 	 	 	 	379,568.24	 	 	 	 	268.18	 	 	 	 	0.00	 	 	 	379,300.06	 	 	 	367,085.87	 	 	 	 	12,214.19	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 
	 	 	 	 	Additional Reporting Items	 	 	Pool I	 	 	 	Pool II	 	 	 	Total	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(a)	 	 	Available Interest
	 	 	 	26,406.29	 	 	 	 	3,642.79	 	 	 	 	30,049.08	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	Available Principal
	 	 	 	330,095.76	 	 	 	 	19,423.40	 	 	 	 	349,519.16	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(b)	 	 	Monthly Interest Amt.
	 	 	see p. 1
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(c)	 	 	Carryforward Interest
	 	 	 	0.00	 	 	 	 	0.00	 	 	 	 	0.00	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(d)	 	 	Principal Paid
	 	 	see p. 1
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(e)	 	 	Class Print Amts.
	 	 	see p. 1
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(f)	 	 	Beginning Actual OC
	 	 	 	2.7000	%	 	 	 	2.0000	%	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	Ending Actual OC
	 	 	 	2.7000	%	 	 	 	2.0000	%	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(g)	 	 	2nd preceding pool bal
	 	 	 	15,968,492.13	 	 	 	 	19,775,393.80	 	 	 	 	35,743,885.93	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(h)	 	 	Required OC
	 	 	 	2.7000	%	 	 	 	2.0000	%	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(i)	 	 	Has Step-up Occurred?
	 	 	No	 	 	No	 	 	 	 	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(k)	 	 	Monies Deposited to Reserve Fund
	 	 	 	137.51	 	 	 	 	0.00	 	 	 	 	137.51	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	Monies Withdrawn from Reserve Fund
	 	 	 	137.51	 	 	 	 	0.00	 	 	 	 	137.51	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 	2.15(l)	 	 	Amts. Dist. to Investor Certificateholders
	 	 	 	11,963.23	 	 	 	 	250.96	 	 	 	 	12,214.19	 
	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Note: Management Fee is to be paid on an annual basis. This month’s Fee together with last
month’s annualized amount equals the full annual Fee.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00078-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00078-of-00352.parquet"}]]